PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
1-Year Return 73.17%
This Quarter Return
+57.5%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$4.47B
AUM Growth
+$1.5B
Cap. Flow
+$491M
Cap. Flow %
10.98%
Top 10 Hldgs %
48.45%
Holding
116
New
21
Increased
27
Reduced
22
Closed
11
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARQT icon
101
Arcutis Biotherapeutics
ARQT
$1.94B
0
BMEA icon
102
Biomea Fusion
BMEA
$107M
-716,441
Closed -$9.86M
ETNB icon
103
89bio
ETNB
$1.28B
0
HRMY icon
104
Harmony Biosciences
HRMY
$2.11B
-996,306
Closed -$32.6M
NVAX icon
105
Novavax
NVAX
$1.21B
0
OM icon
106
Outset Medical
OM
$235M
-44,132
Closed -$7.2M
PRTA icon
107
Prothena Corp
PRTA
$439M
-165,615
Closed -$7.99M
RLAY icon
108
Relay Therapeutics
RLAY
$679M
-1,943,097
Closed -$16.3M
ROIV icon
109
Roivant Sciences
ROIV
$8.76B
-3,819,456
Closed -$44.6M
SLRN
110
DELISTED
ACELYRIN
SLRN
-200,000
Closed -$2.03M
VKTX icon
111
Viking Therapeutics
VKTX
$2.92B
0
XBI icon
112
SPDR S&P Biotech ETF
XBI
$5.23B
0
MOTS
113
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
-6,002
Closed -$40.5K
SLGC
114
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
-1,500,000
Closed -$3.59M
PNT
115
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
0
EQRXW
116
DELISTED
EQRx, Inc. Warrant
EQRXW
-250,000
Closed -$10K